Drug profile · INN
enfortumab vedotin-ejfv
PADCEV
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
enfortumab vedotin-ejfv (PADCEV) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN enfortumab vedotin-ejfv
Brand PADCEV
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is enfortumab vedotin-ejfv?
enfortumab vedotin-ejfv (PADCEV) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for enfortumab vedotin-ejfv?
PADCEV is a marketed brand name for enfortumab vedotin-ejfv. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of enfortumab vedotin-ejfv?
enfortumab vedotin-ejfv has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.